The development of TNF alpha blocker biologics for the treatment of psoriasis, psoriatic arthritis, RA, Crohn's disease, and ankylosing spondylitis is a major breakthrough in the treatment for autoimmune diseases. The gene discussed is TNF; the disease is Crohn disease.